BVD Protection

New Vira Shield 6 from Novartis Animal Health is the first three-way bovine viral diarrhea (BVD) vaccine. It contains Noncytopathic (NCP) Type 1; NCP Type 2, Cytopathic (CP) Type 1.

"In the real world, where the BVD virus is constantly mutating, producers need the most updated and broadest spectrum BVD vaccine available," says John Landon, Novartis bovine marketing manager. "Vira Shield 6 offers broad spectrum protection as it is the first vaccine to contain three BVD antigens."

In addition to BVD, new Vira Shield 6 combinations protect animals against IBR, PI3, BRSV and even H. somnus when producers use new Vira Shield 6+Somnus.

The new product is safe for use in any cow, bull or calf in any stage of production. Vira Shield 6 can be given to calves at pre-weaning and weaning to prepare them for the stresses of weaning and stress from entering the herd or feedlot.

The new product is approved for subcutaneous-only administration, and complements both beef and dairy health programs supporting beef-quality assurance. It contains the proprietary Xtend® SP adjuvant technology for higher immunity over a longer period of time.

For fastest response call

(800) 843-3386